Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression

Identifieur interne : 001E86 ( Main/Corpus ); précédent : 001E85; suivant : 001E87

Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression

Auteurs : P. Richard Schuurman ; D. Andries Bosch ; Maruschka P. Merkus ; Johannes D. Speelman

Source :

RBID : ISTEX:BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B

English descriptors

Abstract

Thalamic stimulation and thalamotomy for treatment of tremor due to Parkinson's disease, essential tremor, and multiple sclerosis were compared in a randomized trial. The symptomatic and functional outcome was studied after 5 years of follow‐up. Sixty‐eight patients were treated (45 Parkinson's disease, 13 essential tremor, 10 multiple sclerosis) by thalamotomy (n = 34) or thalamic stimulation (n = 34). After 5 years, 48 patients were available for follow‐up. The primary outcome measure was change in functional status measured by the Frenchay Activities Index (FAI), scores ranging from 0 to 60. Secondary outcome measures were tremor severity, frequency of complications, and patients' assessment of the outcome. The mean difference in FAI scores between thalamic stimulation and thalamotomy was 4.4 (95% CI: 1.1–7.7) after 6 months, 3.3 (95% CI: −0.03–6.6) after 2 years and 4.0 (95% CI: 0.3–7.7) after 5 years in favor of stimulation. Tremor suppression was equally effective after both procedures, and stable in Parkinson patients. In ET and multiple sclerosis, a diminished effect of stimulation was observed in half of the patients. There were six stimulation equipment‐related complications, but neurological side effects of surgery were higher after thalamotomy. Subjective outcome‐assessment by the patients was more favorable in the stimulation group. © 2008 Movement Disorder Society.

Url:
DOI: 10.1002/mds.22059

Links to Exploration step

ISTEX:BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression</title>
<author>
<name sortKey="Schuurman, P Richard" sort="Schuurman, P Richard" uniqKey="Schuurman P" first="P. Richard" last="Schuurman">P. Richard Schuurman</name>
<affiliation>
<mods:affiliation>Department of Neurosurgery, Academic Medical Center, Amsterdam, The Netherlands</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bosch, D Andries" sort="Bosch, D Andries" uniqKey="Bosch D" first="D. Andries" last="Bosch">D. Andries Bosch</name>
<affiliation>
<mods:affiliation>Department of Neurosurgery, Academic Medical Center, Amsterdam, The Netherlands</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Merkus, Maruschka P" sort="Merkus, Maruschka P" uniqKey="Merkus M" first="Maruschka P." last="Merkus">Maruschka P. Merkus</name>
<affiliation>
<mods:affiliation>Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam, The Netherlands</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Speelman, Johannes D" sort="Speelman, Johannes D" uniqKey="Speelman J" first="Johannes D." last="Speelman">Johannes D. Speelman</name>
<affiliation>
<mods:affiliation>Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands</mods:affiliation>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B</idno>
<date when="2008" year="2008">2008</date>
<idno type="doi">10.1002/mds.22059</idno>
<idno type="url">https://api.istex.fr/document/BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">001E86</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a" type="main" xml:lang="en">Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression</title>
<author>
<name sortKey="Schuurman, P Richard" sort="Schuurman, P Richard" uniqKey="Schuurman P" first="P. Richard" last="Schuurman">P. Richard Schuurman</name>
<affiliation>
<mods:affiliation>Department of Neurosurgery, Academic Medical Center, Amsterdam, The Netherlands</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Bosch, D Andries" sort="Bosch, D Andries" uniqKey="Bosch D" first="D. Andries" last="Bosch">D. Andries Bosch</name>
<affiliation>
<mods:affiliation>Department of Neurosurgery, Academic Medical Center, Amsterdam, The Netherlands</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Merkus, Maruschka P" sort="Merkus, Maruschka P" uniqKey="Merkus M" first="Maruschka P." last="Merkus">Maruschka P. Merkus</name>
<affiliation>
<mods:affiliation>Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam, The Netherlands</mods:affiliation>
</affiliation>
</author>
<author>
<name sortKey="Speelman, Johannes D" sort="Speelman, Johannes D" uniqKey="Speelman J" first="Johannes D." last="Speelman">Johannes D. Speelman</name>
<affiliation>
<mods:affiliation>Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands</mods:affiliation>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="ISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-06-15">2008-06-15</date>
<biblScope unit="volume">23</biblScope>
<biblScope unit="issue">8</biblScope>
<biblScope unit="page" from="1146">1146</biblScope>
<biblScope unit="page" to="1153">1153</biblScope>
</imprint>
<idno type="ISSN">0885-3185</idno>
</series>
<idno type="istex">BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B</idno>
<idno type="DOI">10.1002/mds.22059</idno>
<idno type="ArticleID">MDS22059</idno>
</biblStruct>
</sourceDesc>
<seriesStmt>
<idno type="ISSN">0885-3185</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Parkinson</term>
<term>essential tremor</term>
<term>multiple sclerosis</term>
<term>thalamic stimulation</term>
<term>thalamotomy</term>
<term>tremor</term>
</keywords>
</textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="fr">Thalamic stimulation and thalamotomy for treatment of tremor due to Parkinson's disease, essential tremor, and multiple sclerosis were compared in a randomized trial. The symptomatic and functional outcome was studied after 5 years of follow‐up. Sixty‐eight patients were treated (45 Parkinson's disease, 13 essential tremor, 10 multiple sclerosis) by thalamotomy (n = 34) or thalamic stimulation (n = 34). After 5 years, 48 patients were available for follow‐up. The primary outcome measure was change in functional status measured by the Frenchay Activities Index (FAI), scores ranging from 0 to 60. Secondary outcome measures were tremor severity, frequency of complications, and patients' assessment of the outcome. The mean difference in FAI scores between thalamic stimulation and thalamotomy was 4.4 (95% CI: 1.1–7.7) after 6 months, 3.3 (95% CI: −0.03–6.6) after 2 years and 4.0 (95% CI: 0.3–7.7) after 5 years in favor of stimulation. Tremor suppression was equally effective after both procedures, and stable in Parkinson patients. In ET and multiple sclerosis, a diminished effect of stimulation was observed in half of the patients. There were six stimulation equipment‐related complications, but neurological side effects of surgery were higher after thalamotomy. Subjective outcome‐assessment by the patients was more favorable in the stimulation group. © 2008 Movement Disorder Society.</div>
</front>
</TEI>
<istex>
<corpusName>wiley</corpusName>
<author>
<json:item>
<name>P. Richard Schuurman MD, PhD</name>
<affiliations>
<json:string>Department of Neurosurgery, Academic Medical Center, Amsterdam, The Netherlands</json:string>
</affiliations>
</json:item>
<json:item>
<name>D. Andries Bosch MD, PhD</name>
<affiliations>
<json:string>Department of Neurosurgery, Academic Medical Center, Amsterdam, The Netherlands</json:string>
</affiliations>
</json:item>
<json:item>
<name>Maruschka P. Merkus PhD</name>
<affiliations>
<json:string>Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam, The Netherlands</json:string>
</affiliations>
</json:item>
<json:item>
<name>Johannes D. Speelman MD, PhD</name>
<affiliations>
<json:string>Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands</json:string>
</affiliations>
</json:item>
</author>
<subject>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>thalamic stimulation</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>thalamotomy</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>tremor</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>Parkinson</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>essential tremor</value>
</json:item>
<json:item>
<lang>
<json:string>eng</json:string>
</lang>
<value>multiple sclerosis</value>
</json:item>
</subject>
<articleId>
<json:string>MDS22059</json:string>
</articleId>
<language>
<json:string>eng</json:string>
</language>
<abstract>Thalamic stimulation and thalamotomy for treatment of tremor due to Parkinson's disease, essential tremor, and multiple sclerosis were compared in a randomized trial. The symptomatic and functional outcome was studied after 5 years of follow‐up. Sixty‐eight patients were treated (45 Parkinson's disease, 13 essential tremor, 10 multiple sclerosis) by thalamotomy (n = 34) or thalamic stimulation (n = 34). After 5 years, 48 patients were available for follow‐up. The primary outcome measure was change in functional status measured by the Frenchay Activities Index (FAI), scores ranging from 0 to 60. Secondary outcome measures were tremor severity, frequency of complications, and patients' assessment of the outcome. The mean difference in FAI scores between thalamic stimulation and thalamotomy was 4.4 (95% CI: 1.1–7.7) after 6 months, 3.3 (95% CI: −0.03–6.6) after 2 years and 4.0 (95% CI: 0.3–7.7) after 5 years in favor of stimulation. Tremor suppression was equally effective after both procedures, and stable in Parkinson patients. In ET and multiple sclerosis, a diminished effect of stimulation was observed in half of the patients. There were six stimulation equipment‐related complications, but neurological side effects of surgery were higher after thalamotomy. Subjective outcome‐assessment by the patients was more favorable in the stimulation group. © 2008 Movement Disorder Society.</abstract>
<qualityIndicators>
<score>5.767</score>
<pdfVersion>1.3</pdfVersion>
<pdfPageSize>612 x 810 pts</pdfPageSize>
<refBibsNative>true</refBibsNative>
<keywordCount>6</keywordCount>
<abstractCharCount>1401</abstractCharCount>
<pdfWordCount>3295</pdfWordCount>
<pdfCharCount>23398</pdfCharCount>
<pdfPageCount>8</pdfPageCount>
<abstractWordCount>206</abstractWordCount>
</qualityIndicators>
<title>Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression</title>
<genre>
<json:string>article</json:string>
</genre>
<host>
<volume>23</volume>
<publisherId>
<json:string>MDS</json:string>
</publisherId>
<pages>
<total>8</total>
<last>1153</last>
<first>1146</first>
</pages>
<issn>
<json:string>0885-3185</json:string>
</issn>
<issue>8</issue>
<subject>
<json:item>
<value>Research Article</value>
</json:item>
</subject>
<genre>
<json:string>Journal</json:string>
</genre>
<language>
<json:string>unknown</json:string>
</language>
<eissn>
<json:string>1531-8257</json:string>
</eissn>
<title>Movement Disorders</title>
<doi>
<json:string>10.1002/(ISSN)1531-8257</json:string>
</doi>
</host>
<publicationDate>2008</publicationDate>
<copyrightDate>2008</copyrightDate>
<doi>
<json:string>10.1002/mds.22059</json:string>
</doi>
<id>BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B</id>
<fulltext>
<json:item>
<original>true</original>
<mimetype>application/pdf</mimetype>
<extension>pdf</extension>
<uri>https://api.istex.fr/document/BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B/fulltext/pdf</uri>
</json:item>
<json:item>
<original>false</original>
<mimetype>application/zip</mimetype>
<extension>zip</extension>
<uri>https://api.istex.fr/document/BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B/fulltext/zip</uri>
</json:item>
<istex:fulltextTEI uri="https://api.istex.fr/document/BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B/fulltext/tei">
<teiHeader>
<fileDesc>
<titleStmt>
<title level="a" type="main" xml:lang="en">Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression</title>
</titleStmt>
<publicationStmt>
<authority>ISTEX</authority>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<availability>
<p>WILEY</p>
</availability>
<date>2008</date>
</publicationStmt>
<sourceDesc>
<biblStruct type="inbook">
<analytic>
<title level="a" type="main" xml:lang="en">Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression</title>
<author>
<persName>
<forename type="first">P. Richard</forename>
<surname>Schuurman</surname>
</persName>
<roleName type="degree">MD, PhD</roleName>
<note type="correspondence">
<p>Correspondence: Department of Neurosurgery, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands</p>
</note>
<affiliation>Department of Neurosurgery, Academic Medical Center, Amsterdam, The Netherlands</affiliation>
</author>
<author>
<persName>
<forename type="first">D. Andries</forename>
<surname>Bosch</surname>
</persName>
<roleName type="degree">MD, PhD</roleName>
<affiliation>Department of Neurosurgery, Academic Medical Center, Amsterdam, The Netherlands</affiliation>
</author>
<author>
<persName>
<forename type="first">Maruschka P.</forename>
<surname>Merkus</surname>
</persName>
<roleName type="degree">PhD</roleName>
<affiliation>Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam, The Netherlands</affiliation>
</author>
<author>
<persName>
<forename type="first">Johannes D.</forename>
<surname>Speelman</surname>
</persName>
<roleName type="degree">MD, PhD</roleName>
<affiliation>Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands</affiliation>
</author>
</analytic>
<monogr>
<title level="j">Movement Disorders</title>
<title level="j" type="sub">Official Journal of the Movement Disorder Society</title>
<title level="j" type="abbrev">Mov. Disord.</title>
<idno type="pISSN">0885-3185</idno>
<idno type="eISSN">1531-8257</idno>
<idno type="DOI">10.1002/(ISSN)1531-8257</idno>
<imprint>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<pubPlace>Hoboken</pubPlace>
<date type="published" when="2008-06-15"></date>
<biblScope unit="volume">23</biblScope>
<biblScope unit="issue">8</biblScope>
<biblScope unit="page" from="1146">1146</biblScope>
<biblScope unit="page" to="1153">1153</biblScope>
</imprint>
</monogr>
<idno type="istex">BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B</idno>
<idno type="DOI">10.1002/mds.22059</idno>
<idno type="ArticleID">MDS22059</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<creation>
<date>2008</date>
</creation>
<langUsage>
<language ident="en">en</language>
</langUsage>
<abstract xml:lang="fr">
<p>Thalamic stimulation and thalamotomy for treatment of tremor due to Parkinson's disease, essential tremor, and multiple sclerosis were compared in a randomized trial. The symptomatic and functional outcome was studied after 5 years of follow‐up. Sixty‐eight patients were treated (45 Parkinson's disease, 13 essential tremor, 10 multiple sclerosis) by thalamotomy (n = 34) or thalamic stimulation (n = 34). After 5 years, 48 patients were available for follow‐up. The primary outcome measure was change in functional status measured by the Frenchay Activities Index (FAI), scores ranging from 0 to 60. Secondary outcome measures were tremor severity, frequency of complications, and patients' assessment of the outcome. The mean difference in FAI scores between thalamic stimulation and thalamotomy was 4.4 (95% CI: 1.1–7.7) after 6 months, 3.3 (95% CI: −0.03–6.6) after 2 years and 4.0 (95% CI: 0.3–7.7) after 5 years in favor of stimulation. Tremor suppression was equally effective after both procedures, and stable in Parkinson patients. In ET and multiple sclerosis, a diminished effect of stimulation was observed in half of the patients. There were six stimulation equipment‐related complications, but neurological side effects of surgery were higher after thalamotomy. Subjective outcome‐assessment by the patients was more favorable in the stimulation group. © 2008 Movement Disorder Society.</p>
</abstract>
<textClass xml:lang="en">
<keywords scheme="keyword">
<list>
<head>Keywords</head>
<item>
<term>thalamic stimulation</term>
</item>
<item>
<term>thalamotomy</term>
</item>
<item>
<term>tremor</term>
</item>
<item>
<term>Parkinson</term>
</item>
<item>
<term>essential tremor</term>
</item>
<item>
<term>multiple sclerosis</term>
</item>
</list>
</keywords>
</textClass>
<textClass>
<keywords scheme="Journal Subject">
<list>
<head>article category</head>
<item>
<term>Research Article</term>
</item>
</list>
</keywords>
</textClass>
</profileDesc>
<revisionDesc>
<change when="2006-07-27">Received</change>
<change when="2008-03-01">Registration</change>
<change when="2008-06-15">Published</change>
</revisionDesc>
</teiHeader>
</istex:fulltextTEI>
<json:item>
<original>false</original>
<mimetype>text/plain</mimetype>
<extension>txt</extension>
<uri>https://api.istex.fr/document/BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B/fulltext/txt</uri>
</json:item>
</fulltext>
<metadata>
<istex:metadataXml wicri:clean="Wiley, elements deleted: body">
<istex:xmlDeclaration>version="1.0" encoding="UTF-8" standalone="yes"</istex:xmlDeclaration>
<istex:document>
<component version="2.0" type="serialArticle" xml:lang="en">
<header>
<publicationMeta level="product">
<publisherInfo>
<publisherName>Wiley Subscription Services, Inc., A Wiley Company</publisherName>
<publisherLoc>Hoboken</publisherLoc>
</publisherInfo>
<doi registered="yes">10.1002/(ISSN)1531-8257</doi>
<issn type="print">0885-3185</issn>
<issn type="electronic">1531-8257</issn>
<idGroup>
<id type="product" value="MDS"></id>
</idGroup>
<titleGroup>
<title type="main" xml:lang="en" sort="MOVEMENT DISORDERS">Movement Disorders</title>
<title type="subtitle">Official Journal of the Movement Disorder Society</title>
<title type="short">Mov. Disord.</title>
</titleGroup>
</publicationMeta>
<publicationMeta level="part" position="80">
<doi origin="wiley" registered="yes">10.1002/mds.v23:8</doi>
<numberingGroup>
<numbering type="journalVolume" number="23">23</numbering>
<numbering type="journalIssue">8</numbering>
</numberingGroup>
<coverDate startDate="2008-06-15">15 June 2008</coverDate>
</publicationMeta>
<publicationMeta level="unit" type="article" position="110" status="forIssue">
<doi origin="wiley" registered="yes">10.1002/mds.22059</doi>
<idGroup>
<id type="unit" value="MDS22059"></id>
</idGroup>
<countGroup>
<count type="pageTotal" number="8"></count>
</countGroup>
<titleGroup>
<title type="articleCategory">Research Article</title>
<title type="tocHeading1">Research Articles</title>
</titleGroup>
<copyright ownership="thirdParty">Copyright © 2008 Movement Disorder Society</copyright>
<eventGroup>
<event type="manuscriptReceived" date="2006-07-27"></event>
<event type="manuscriptRevised" date="2008-02-05"></event>
<event type="manuscriptAccepted" date="2008-03-01"></event>
<event type="publishedOnlineEarlyUnpaginated" date="2008-04-28"></event>
<event type="firstOnline" date="2008-04-28"></event>
<event type="publishedOnlineFinalForm" date="2008-06-24"></event>
<event type="xmlConverted" agent="Converter:JWSART34_TO_WML3G version:2.3.2 mode:FullText source:FullText result:FullText" date="2010-03-09"></event>
<event type="xmlConverted" agent="Converter:WILEY_ML3G_TO_WILEY_ML3GV2 version:3.8.8" date="2014-02-02"></event>
<event type="xmlConverted" agent="Converter:WML3G_To_WML3G version:4.1.7 mode:FullText,remove_FC" date="2014-10-31"></event>
</eventGroup>
<numberingGroup>
<numbering type="pageFirst">1146</numbering>
<numbering type="pageLast">1153</numbering>
</numberingGroup>
<correspondenceTo>Department of Neurosurgery, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands</correspondenceTo>
<linkGroup>
<link type="toTypesetVersion" href="file:MDS.MDS22059.pdf"></link>
</linkGroup>
</publicationMeta>
<contentMeta>
<countGroup>
<count type="figureTotal" number="2"></count>
<count type="tableTotal" number="4"></count>
<count type="referenceTotal" number="19"></count>
<count type="wordTotal" number="5267"></count>
</countGroup>
<titleGroup>
<title type="main" xml:lang="en">Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression</title>
<title type="short" xml:lang="en">Thalamic Stimulation and Thalamotomy: 5 Years</title>
</titleGroup>
<creators>
<creator xml:id="au1" creatorRole="author" affiliationRef="#af1" corresponding="yes">
<personName>
<givenNames>P. Richard</givenNames>
<familyName>Schuurman</familyName>
<degrees>MD, PhD</degrees>
</personName>
<contactDetails>
<email>p.r.schuurman@amc.nl</email>
</contactDetails>
</creator>
<creator xml:id="au2" creatorRole="author" affiliationRef="#af1">
<personName>
<givenNames>D. Andries</givenNames>
<familyName>Bosch</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
<creator xml:id="au3" creatorRole="author" affiliationRef="#af2">
<personName>
<givenNames>Maruschka P.</givenNames>
<familyName>Merkus</familyName>
<degrees>PhD</degrees>
</personName>
</creator>
<creator xml:id="au4" creatorRole="author" affiliationRef="#af3">
<personName>
<givenNames>Johannes D.</givenNames>
<familyName>Speelman</familyName>
<degrees>MD, PhD</degrees>
</personName>
</creator>
</creators>
<affiliationGroup>
<affiliation xml:id="af1" countryCode="NL" type="organization">
<unparsedAffiliation>Department of Neurosurgery, Academic Medical Center, Amsterdam, The Netherlands</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af2" countryCode="NL" type="organization">
<unparsedAffiliation>Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam, The Netherlands</unparsedAffiliation>
</affiliation>
<affiliation xml:id="af3" countryCode="NL" type="organization">
<unparsedAffiliation>Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands</unparsedAffiliation>
</affiliation>
</affiliationGroup>
<keywordGroup xml:lang="en" type="author">
<keyword xml:id="kwd1">thalamic stimulation</keyword>
<keyword xml:id="kwd2">thalamotomy</keyword>
<keyword xml:id="kwd3">tremor</keyword>
<keyword xml:id="kwd4">Parkinson</keyword>
<keyword xml:id="kwd5">essential tremor</keyword>
<keyword xml:id="kwd6">multiple sclerosis</keyword>
</keywordGroup>
<abstractGroup>
<abstract type="main" xml:lang="fr">
<title type="main">Abstract</title>
<p>Thalamic stimulation and thalamotomy for treatment of tremor due to Parkinson's disease, essential tremor, and multiple sclerosis were compared in a randomized trial. The symptomatic and functional outcome was studied after 5 years of follow‐up. Sixty‐eight patients were treated (45 Parkinson's disease, 13 essential tremor, 10 multiple sclerosis) by thalamotomy (n = 34) or thalamic stimulation (n = 34). After 5 years, 48 patients were available for follow‐up. The primary outcome measure was change in functional status measured by the Frenchay Activities Index (FAI), scores ranging from 0 to 60. Secondary outcome measures were tremor severity, frequency of complications, and patients' assessment of the outcome. The mean difference in FAI scores between thalamic stimulation and thalamotomy was 4.4 (95% CI: 1.1–7.7) after 6 months, 3.3 (95% CI: −0.03–6.6) after 2 years and 4.0 (95% CI: 0.3–7.7) after 5 years in favor of stimulation. Tremor suppression was equally effective after both procedures, and stable in Parkinson patients. In ET and multiple sclerosis, a diminished effect of stimulation was observed in half of the patients. There were six stimulation equipment‐related complications, but neurological side effects of surgery were higher after thalamotomy. Subjective outcome‐assessment by the patients was more favorable in the stimulation group. © 2008 Movement Disorder Society.</p>
</abstract>
</abstractGroup>
</contentMeta>
</header>
</component>
</istex:document>
</istex:metadataXml>
<mods version="3.6">
<titleInfo lang="en">
<title>Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression</title>
</titleInfo>
<titleInfo type="abbreviated" lang="en">
<title>Thalamic Stimulation and Thalamotomy: 5 Years</title>
</titleInfo>
<titleInfo type="alternative" contentType="CDATA" lang="en">
<title>Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression</title>
</titleInfo>
<name type="personal">
<namePart type="given">P. Richard</namePart>
<namePart type="family">Schuurman</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>Department of Neurosurgery, Academic Medical Center, Amsterdam, The Netherlands</affiliation>
<description>Correspondence: Department of Neurosurgery, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands</description>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">D. Andries</namePart>
<namePart type="family">Bosch</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>Department of Neurosurgery, Academic Medical Center, Amsterdam, The Netherlands</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Maruschka P.</namePart>
<namePart type="family">Merkus</namePart>
<namePart type="termsOfAddress">PhD</namePart>
<affiliation>Department of Clinical Epidemiology and Biostatistics, Academic Medical Center, Amsterdam, The Netherlands</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<name type="personal">
<namePart type="given">Johannes D.</namePart>
<namePart type="family">Speelman</namePart>
<namePart type="termsOfAddress">MD, PhD</namePart>
<affiliation>Department of Neurology, Academic Medical Center, Amsterdam, The Netherlands</affiliation>
<role>
<roleTerm type="text">author</roleTerm>
</role>
</name>
<typeOfResource>text</typeOfResource>
<genre type="article" displayLabel="article"></genre>
<originInfo>
<publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher>
<place>
<placeTerm type="text">Hoboken</placeTerm>
</place>
<dateIssued encoding="w3cdtf">2008-06-15</dateIssued>
<dateCaptured encoding="w3cdtf">2006-07-27</dateCaptured>
<dateValid encoding="w3cdtf">2008-03-01</dateValid>
<copyrightDate encoding="w3cdtf">2008</copyrightDate>
</originInfo>
<language>
<languageTerm type="code" authority="rfc3066">en</languageTerm>
<languageTerm type="code" authority="iso639-2b">eng</languageTerm>
</language>
<physicalDescription>
<internetMediaType>text/html</internetMediaType>
<extent unit="figures">2</extent>
<extent unit="tables">4</extent>
<extent unit="references">19</extent>
<extent unit="words">5267</extent>
</physicalDescription>
<abstract lang="fr">Thalamic stimulation and thalamotomy for treatment of tremor due to Parkinson's disease, essential tremor, and multiple sclerosis were compared in a randomized trial. The symptomatic and functional outcome was studied after 5 years of follow‐up. Sixty‐eight patients were treated (45 Parkinson's disease, 13 essential tremor, 10 multiple sclerosis) by thalamotomy (n = 34) or thalamic stimulation (n = 34). After 5 years, 48 patients were available for follow‐up. The primary outcome measure was change in functional status measured by the Frenchay Activities Index (FAI), scores ranging from 0 to 60. Secondary outcome measures were tremor severity, frequency of complications, and patients' assessment of the outcome. The mean difference in FAI scores between thalamic stimulation and thalamotomy was 4.4 (95% CI: 1.1–7.7) after 6 months, 3.3 (95% CI: −0.03–6.6) after 2 years and 4.0 (95% CI: 0.3–7.7) after 5 years in favor of stimulation. Tremor suppression was equally effective after both procedures, and stable in Parkinson patients. In ET and multiple sclerosis, a diminished effect of stimulation was observed in half of the patients. There were six stimulation equipment‐related complications, but neurological side effects of surgery were higher after thalamotomy. Subjective outcome‐assessment by the patients was more favorable in the stimulation group. © 2008 Movement Disorder Society.</abstract>
<subject lang="en">
<genre>Keywords</genre>
<topic>thalamic stimulation</topic>
<topic>thalamotomy</topic>
<topic>tremor</topic>
<topic>Parkinson</topic>
<topic>essential tremor</topic>
<topic>multiple sclerosis</topic>
</subject>
<relatedItem type="host">
<titleInfo>
<title>Movement Disorders</title>
<subTitle>Official Journal of the Movement Disorder Society</subTitle>
</titleInfo>
<titleInfo type="abbreviated">
<title>Mov. Disord.</title>
</titleInfo>
<genre type="Journal">journal</genre>
<subject>
<genre>article category</genre>
<topic>Research Article</topic>
</subject>
<identifier type="ISSN">0885-3185</identifier>
<identifier type="eISSN">1531-8257</identifier>
<identifier type="DOI">10.1002/(ISSN)1531-8257</identifier>
<identifier type="PublisherID">MDS</identifier>
<part>
<date>2008</date>
<detail type="volume">
<caption>vol.</caption>
<number>23</number>
</detail>
<detail type="issue">
<caption>no.</caption>
<number>8</number>
</detail>
<extent unit="pages">
<start>1146</start>
<end>1153</end>
<total>8</total>
</extent>
</part>
</relatedItem>
<identifier type="istex">BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B</identifier>
<identifier type="DOI">10.1002/mds.22059</identifier>
<identifier type="ArticleID">MDS22059</identifier>
<accessCondition type="use and reproduction" contentType="copyright">Copyright © 2008 Movement Disorder Society</accessCondition>
<recordInfo>
<recordContentSource>WILEY</recordContentSource>
<recordOrigin>Wiley Subscription Services, Inc., A Wiley Company</recordOrigin>
</recordInfo>
</mods>
</metadata>
<serie></serie>
</istex>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001E86 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Corpus/biblio.hfd -nk 001E86 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Corpus
   |type=    RBID
   |clé=     ISTEX:BEBAD44BDCC45A1BCD703EB8DE8673BA8742C25B
   |texte=   Long‐term follow‐up of thalamic stimulation versus thalamotomy for tremor suppression
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024